March 9th 2023
A new survey from HealthTree Foundation and Adaptive Biotechnologies shows that patients with multiple myeloma report significant clinical and emotional benefits from MRD testing and 90% of patients who have had MRD testing would recommend it to others, underscoring its benefits and providing support for broad clinical use.
March 6th 2023
By Sponsored Content
March 2nd 2023
December 2nd 2022
This article is sponsored by AstraZeneca and Merck.
November 23rd 2022
By Sponsored Content by Boston Scientific Corporation
A Navy veteran and football coach tackles prostate cancer diagnosis, with family’s support.
October 31st 2022
By Sponsored by Astellas Pharma US, Inc.
Dr. Eunice Wang shares the importance of staying informed about AML subtypes and genetic mutations like FMS-like tyrosine kinase 3 (FLT3), getting tested and engaging your caregiver team
October 26th 2022
Sponsored Content by Daiichi Sankyo
September 26th 2022
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) cancer survivor Louise (left) and her oncologist, Dr. Ruemu Birhiray (right), built a lasting relationship as they navigated Louise’s diagnosis and relapse. This article is sponsored by MorphoSys and Incyte.
September 16th 2022
Sponsored by Incyte
September 13th 2022
This article is sponsored Astellas Pharma US, Inc.
This article is sponsored by Aadi Bioscience, Inc.
June 3rd 2022
City of Hope sets the bar for treating people, not just diseases.
May 1st 2022
Care partners need help, too! That’s why this informational booklet was created. It’s full of practical advice from people who have been in your shoes, caring for someone with non-small cell lung cancer.
March 31st 2022
Learn about the disproportionate impact that the COVID-19 pandemic has on immunocompromised patients with chronic lymphocytic leukemia (CLL), and hear potential solutions from leading CLL experts.
March 22nd 2022
Cindy Cherry, MSN, AGNP-C, and cancer patient Dorothy T. share their experiences with cancer and how they approach chemotherapy treatment.
February 9th 2022
Sponsored by Takeda Oncology. Lisa Cruz, Patient Advocacy Lead, Takeda Oncology and Marcia K. Horn, Executive Director, Exon 20 Group at ICAN, International Cancer Advocacy Network
February 1st 2022
Learn from survivors! Find out more about care communities, biomarker testing, and how to make the most of every appointment.
December 7th 2021
November 30th 2021
November 4th 2021
Cindy Cherry, MSN, AGNP-C, is an oncology nurse practitioner in Greenville, North Carolina. She treats patients with all types of cancers, including extensive-stage small cell lung cancer (ES-SCLC).
October 8th 2021
Learn more about the protection of bone marrow and how it may help lower the risk of bone marrow suppression for certain people with small cell lung cancer.
September 13th 2021
In this episode of the “Cure Talks Cancer” Podcast, Dr. Spira a medical oncologist of the Virginia Cancer Specialists’ (VCS) discusses why KRASG12C is a prolific problem.
May 28th 2021
By CURE staff
Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.
March 17th 2021
An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center
February 19th 2021
Treating CLL with CALQUENCE® (acalabrutinib)
January 27th 2021
There are multiple treatment patients for patients with cholangiocarcinoma, here's what you need to know about them.
December 17th 2020
A clinical research coordinator discusses how patients with cholangiocarcinoma can get involved in clinical trials, such as the phase 3 PROOF trial, as well as what they should know once they are enrolled.
By SPONSORED BY SANOFI
As the treatment landscape for multiple myeloma continues to evolve, it is key for patients to find a specialist in the field, ask questions and learn more about their options.
December 7th 2020
Dr. Yuliya Linhares discusses cutaneous T-cell lymphoma and the role of a multidisciplinary team of specialists in designing and managing care.
October 23rd 2020
By Sponsored by HandsFree Health
"WellBe was developed to provide meaningful health information on cancer while staying connected to loved ones with our calling and messaging capabilities.”
Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma
FDA Oncology Approval From Spring 2023
The Importance of Age- and Disease-Specific Cancer Support
The Emerging Importance of Immunotherapy in Endometrial Cancer